Hence, while more research is needed, it seems that an increase of ABCA7 expression may lead to a higher risk of specific cancer-type development, which is opposite to ABCA7 loss-of-function as a pathomechanism of AD. This evidence concerns the gene ABCA7 and Alzheimer disease.